Search

Search Constraints

You searched for: Author/Creator Matrone, Antonio

Search Results

1. Chylous effusions in advanced medullary thyroid cancer patients treated with selpercatinib. Issue 6 (29th November 2022)

3. Medullary thyroid cancer treated with vandetanib: predictors of a longer and durable response. Issue 2 (February 2020)

4. Medullary thyroid cancer treated with vandetanib: predictors of a longer and durable response. Issue 2 (February 2020)

5. New insights in the molecular signature of advanced medullary thyroid cancer: evidence of a bad outcome of cases with double RET mutations. Issue 11 (28th July 2016)

6. No difference in the outcome of metastatic thyroid cancer patients when using recombinant or endogenous TSH. Issue 4 (October 2020)

7. No difference in the outcome of metastatic thyroid cancer patients when using recombinant or endogenous TSH. Issue 4 (October 2020)

9. P38α Is Required for Ovarian Cancer Cell Metabolism and Survival. Issue 2 (1st February 2010)

10. Prevalence and Risk Factors of Developing Fistula or Organ Perforation in Patients Treated with Lenvatinib for Radioiodine-Refractory Thyroid Cancer. Issue 5 (23rd July 2021)